Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemia

Despite advances in the treatment of T-cell acute lymphoblastic leukemia (T-ALL), the outcome of T-ALL treatment remains unsatisfactory, therefore, more effective treatment is urgently required. The present study examined the cytotoxicities of bortezomib in combination with daunorubicin against huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Xin, Tong, Jia, Lu, Hongying, He, Cong, Du, Shenghong, Jia, Peimin, Zhao, Weili, Xu, Hanzhang, Li, Junmin, Shen, Zhixiang, Wu, Yingli, Tong, Jianhua, Zhou, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482122/
https://www.ncbi.nlm.nih.gov/pubmed/28487980
http://dx.doi.org/10.3892/mmr.2017.6554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482122/
https://www.ncbi.nlm.nih.gov/pubmed/28487980
http://dx.doi.org/10.3892/mmr.2017.6554

Ejemplares similares